Report cover image

Emerging Therapeutics for Neurodegenerative Diseases, Global, 2025-2030

Publisher Frost & Sullivan
Published Aug 19, 2025
SKU # MC20334538

Description

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature of competition and geopolitical upheaval).

The report will examine emerging therapeutic modalities including biologics (monoclonal antibodies and nucleic acid therapies), small molecules (amyloidogenesis inhibitors and NMDA antagonists), and alternative therapies (clinical nutraceuticals and microbiome). It also examines essential strategies such as convergence and disruption, as well as pipeline reviews of major emerging drugs and devices from prominent academic and industry participants. It pinpoints high-growth opportunities, such as disease-modifying therapies, immunotherapy drug products, and precision medicine along with funding trends and collaborations with strategic partners.

The study integrates technological, clinical, and market trends to provide actionable recommendations to stakeholders and emphasize the high-growth, multitrillion-dollar opportunities in the emerging neurodegenerative therapeutics space.

Table of Contents

    • Why Is It Increasingly Difficult to Grow?
    • The Strategic Imperative 8
    • The Impact of the Top 3 Strategic Imperatives on Emerging Therapeutics for Neurodegenerative Diseases
    • Growth Opportunities Fuel the Growth Pipeline Engine ne
    • Research Methodology
    • Scope of Analysis
    • Segmentation
    • Growth Drivers
    • Growth Restraints
    • Neurodegenerative Diseases: Facts and Challenges
    • Understanding the Most Prevalent and Impactful Disorders of the Aging Brain
    • Alzheimer’s and Parkinson’s Diseases Are the Leading Neurodegenerative Disorders
    • Neurodegenerative Diseases: Emerging Therapies Under Biologics
    • Mechanism and Clinical Applications: Nucleic Acid Therapies
    • Mechanism and Clinical Applications: Monoclonal Antibodies
    • Mechanism and Clinical Applications: Microbiome-Based Therapies
    • Neurodegenerative Diseases: Emerging Therapies Under Small Molecules
    • Mechanism and Clinical Applications: Amyloidogenesis Inhibitors
    • Mechanism and Clinical Applications: NMDA Receptor Antagonist
    • Mechanism and Clinical Applications: Cholinesterase Inhibitors
    • Neurodegenerative Diseases: Alternative Therapies
    • Mechanism and Clinical Applications: Nutraceuticals
    • Mechanism and Clinical Applications: Ayurvedic and Traditional Practices
    • Clinical Pipeline Overview for Alzheimer's
    • Clinical Pipeline Innovator Profiles
    • Clinical Pipeline Overview for Parkinson’s
    • Clinical Pipeline Innovator Profiles
    • Funding Analysis
    • Key Partnerships and Acquisitions
    • Innovative Biologic Delivery Systems Outlook
    • Target-Specific Monoclonal Antibodies Outlook
    • Gene Therapy and Genetic Engineering Outlook
    • Growth Opportunity 1: Advancements in Precision Medicine and Personalized Therapies
    • Growth Opportunity 2: Breakthroughs in Disease-Modifying Therapies
    • Growth Opportunity 3: Advancing Immunotherapeutic Approaches
    • Benefits and Impacts of Growth Opportunities
    • Next Steps

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us